LEUNG SANDRA
SEC CIK 1199294 · EDGAR
BoughtSold
Most active insiders at BHC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PAULSON & CO. INC. | 10% | $15.62M | — |
| 2 | Lenar Aimee J. | Pres, US Pharma | — | $258.9K |
| 3 | Lee Frank D. | Dir | — | $132.8K |
| 4 | Carson Seana | EVP, GC | — | $115.0K |
| 5 | LEE STEVEN HYOSIG | SVP, CAO, Ctrl | — | — |
| 6 | GOETTLER MICHAEL | Dir | — | — |
| 7 | ROBERTS EIRY | Dir | — | — |
| 8 | Charhon Jean-Jacques | EVP, CFO | — | — |
| 9 | APPIO THOMAS | CEO, Dir | — | — |
| 10 | KAVANAGH SARAH B | Dir | — | — |
| 14 | LEUNG SANDRA | Dir | — | — |
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 16:10 | 2026-06-30 | BHC | Bausch Health Companies Inc. | LEUNG SANDRA | Dir | A - Grant | $4.93 | +6,845 | 97.1K | +8% | +$33.7K | |
| 2026-05-26 18:30 | 2026-05-22 | BHC | Bausch Health Companies Inc. | LEUNG SANDRA | Dir | A - Grant | $0.00 | +45.9K | 90.2K | +103% | $0 | |
| 2026-04-02 18:30 | 2026-03-31 | BHC | Bausch Health Companies Inc. | LEUNG SANDRA | Dir | A - Grant | $5.40 | +5,946 | 44.4K | +15% | +$32.1K | |
| 2026-01-02 | 2025-12-31 | BHC | Bausch Health Companies Inc. | LEUNG SANDRA | Dir | A - Grant | $0.00 | +4,586 | 38.4K | +14% | $0 | |
| 2025-10-02 | 2025-09-30 | BHC | Bausch Health Companies Inc. | LEUNG SANDRA | Dir | A - Grant | $0.00 | +3,673 | 33.8K | +12% | $0 | |
| 2025-07-29 | 2025-07-25 | BHC | Bausch Health Companies Inc. | LEUNG SANDRA | Dir | A - Grant | $0.00 | +30.1K | 30.1K | New | $0 | |
| DM | 2025-03-12 | 2025-03-10 | BMY | Bristol Myers Squibb | LEUNG SANDRA | EVP, GC | F - Tax | $63.11 | -17.7K | 354.4K | -5% | -$1.12M |
| DM | 2025-03-12 | 2025-03-10 | BMY | Bristol Myers Squibb | LEUNG SANDRA | EVP, GC | J - Other | $0.00 | -14.1K | 374.7K | -4% | $0 |
| DM | 2025-03-12 | 2025-03-10 | BMY | Bristol Myers Squibb | LEUNG SANDRA | EVP, GC | M - OptEx | $0.00 | +48.7K | 386.5K | +14% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Bristol Myers Squibb | LEUNG SANDRA | EVP, GC | F - Tax | $53.79 | -16.7K | 333.8K | -5% | -$896.1K |
| DM | 2024-03-12 | 2024-03-10 | BMY | Bristol Myers Squibb | LEUNG SANDRA | EVP, GC | M - OptEx | $0.00 | +46.8K | 339.7K | +16% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Bristol Myers Squibb | LEUNG SANDRA | EVP, GC | J - Other | $0.00 | -14.2K | 336.3K | -4% | $0 |
| 2023-11-24 | 2023-11-21 | BMY | Bristol Myers Squibb | LEUNG SANDRA | EVP, GC | J - Other | $48.75 | -9,830 | 331.4K | -3% | -$479.2K | |
| I | 2023-11-24 | 2023-11-21 | BMY | Bristol Myers Squibb | LEUNG SANDRA | EVP, GC | J - Other | $48.75 | +9,830 | 93.4K | +12% | +$479.2K |
| DM | 2023-03-14 | 2023-03-10 | BMY | Bristol Myers Squibb | LEUNG SANDRA | EVP, GC | M - OptEx | $0.00 | +58.0K | 356.9K | +19% | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | Bristol Myers Squibb | LEUNG SANDRA | EVP, GC | F - Tax | $65.71 | -34.1K | 322.2K | -10% | -$2.24M |
| DM | 2023-03-14 | 2023-03-10 | BMY | Bristol Myers Squibb | LEUNG SANDRA | EVP, GC | J - Other | $0.00 | +8,731 | 317.2K | +3% | $0 |
| 2022-06-07 | 2022-06-06 | BMY | Bristol Myers Squibb | LEUNG SANDRA | EVP, GC | S - Sale | $74.89 | -65.0K | 308.6K | -17% | -$4.87M | |
| DM | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | LEUNG SANDRA | EVP, GC | M - OptEx | $0.00 | +60.3K | 388.7K | +18% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | LEUNG SANDRA | EVP, GC | J - Other | $0.00 | +18.3K | 403.6K | +5% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | LEUNG SANDRA | EVP, GC | F - Tax | $68.42 | -44.9K | 373.6K | -11% | -$3.07M |
| 2021-08-03 | 2021-07-30 | BMY | Bristol Myers Squibb | LEUNG SANDRA | EVP, GC | S - Sale | $68.04 | -29.4K | 340.0K | -8% | -$2.00M |
Purchase Sale Sale after option exercise All abbreviations